PF 4217903
Alternative Names: PF-04217903; PF-4217903; PF-4217903-ALatest Information Update: 04 Mar 2011
Price :
$50 *
At a glance
- Originator Pfizer
- Class Amino alcohols; Antineoplastics; Heterocyclic bicyclo compounds; Small molecules
- Mechanism of Action Proto-oncogene protein c-met inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 28 Feb 2011 Discontinued - Phase-I for Cancer in USA (PO)
- 27 Jul 2010 Suspended - Phase-I for Cancer in USA (PO)
- 19 Mar 2010 Pfizer completes enrolment in its phase I trial for Cancer in USA